$1.10
0.000.00%
Pre-Market: 6:37 AM EDT
Comments
Loading...
Immunic Earnings Estimates, EPS & Revenue | NASDAQ:IMUX | Benzinga
Immunic reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 25
EPS Estimate
$-0.240
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Immunic using advanced sorting and filters.
Data brought to you by Benzinga APIs
Immunic (IMUX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.24 | $-0.22 | -9.09 % |
| Q2 | 2024-08-08 | $-0.21 | $-0.23 | 8.70 % |
| Q1 | 2024-05-08 | $-0.30 | $-0.26 | -15.4 % |
| Q4 | 2024-02-22 | $-0.48 | $-0.51 | 5.88 % |
Immunic (IMUX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Immunic (NASDAQ:IMUX) reporting earnings?
Immunic (IMUX) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Immunic (NASDAQ:IMUX)?
The Actual EPS was $-0.24, which missed the estimate of $-0.22.
What were Immunic’s (NASDAQ:IMUX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.